Dr Matteo Serenelli
- Affiliate (School of Cardiovascular & Metabolic Health)
Publications
2022
Yeoh, Su Ern, Dewan, Pooja 
ORCID: https://orcid.org/0000-0003-2927-4075, Serenelli, Matteo, Ferreira, Joao Pedro, Pitt, Bertram, Swedberg, Karl, Veldhuisen, Dirk J., Zannad, Faiez, Jhund, Pardeep S. ORCID: https://orcid.org/0000-0003-4306-5317 and McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975
(2022)
Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and RALES.
European Journal of Heart Failure, 24(3),
pp. 529-538.
(doi: 10.1002/ejhf.2350)
(PMID:34536265)
(PMCID:PMC10654446)
2020
Serenelli, M. et al. (2020) Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF). European Heart Journal, 41(36), pp. 3402-3418. (doi: 10.1093/eurheartj/ehaa496) (PMID:32820334) (PMCID:PMC7550197)
Serenelli, M. et al. (2020) Mineralocorticoid receptor antagonists, blood pressure, and outcomes in heart failure with reduced ejection fraction. JACC: Heart Failure, 8(3), pp. 188-198. (doi: 10.1016/j.jchf.2019.09.011) (PMID:31926854) (PMCID:PMC7086149)
Articles
Yeoh, Su Ern, Dewan, Pooja ORCID: https://orcid.org/0000-0003-2927-4075, Serenelli, Matteo, Ferreira, Joao Pedro, Pitt, Bertram, Swedberg, Karl, Veldhuisen, Dirk J., Zannad, Faiez, Jhund, Pardeep S. ORCID: https://orcid.org/0000-0003-4306-5317 and McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975
(2022)
Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and RALES.
European Journal of Heart Failure, 24(3),
pp. 529-538.
(doi: 10.1002/ejhf.2350)
(PMID:34536265)
(PMCID:PMC10654446)
Serenelli, M. et al. (2020) Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF). European Heart Journal, 41(36), pp. 3402-3418. (doi: 10.1093/eurheartj/ehaa496) (PMID:32820334) (PMCID:PMC7550197)
Serenelli, M. et al. (2020) Mineralocorticoid receptor antagonists, blood pressure, and outcomes in heart failure with reduced ejection fraction. JACC: Heart Failure, 8(3), pp. 188-198. (doi: 10.1016/j.jchf.2019.09.011) (PMID:31926854) (PMCID:PMC7086149)